Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-03-31EMA Authorised: Vaxelis (Diphtheria toxoid;tetanus toxoid;Bordetella pertussis antigens: pertussis toxoid, filamentous haemagglutinin, pertactin, fimbriae Types 2 and 3;hepatitis B surface antigen produced in yeast cells;poliovirus (inactivated): type 1 (Mahoney), type 2 (MEF-1), type 3 (Saukett) produced in Vero cells/ Haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) conjugated to meningococcal protein.) — MCM Vaccine B.V.
The EMA has authorised Vaxelis, a combination vaccine containing diphtheria and tetanus toxoids, pertussis antigens, hepatitis B surface ant…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic Fibrosis and Liver Cirrhosis [Phase 3]
A Phase 3 clinical trial evaluating the safety of Hydronidone capsules in patients with hepatic fibrosis and liver cirrhosis due to chronic …
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection
Updates on a completed NIH clinical trial examining the epidemiology, infectivity, and natural history of hepatitis C virus infection (also …
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Oral-Periodontal Evaluation and Assessment of Oral Fluid Biomarkers in Patients With Hepatitis B+D
This clinical trial update describes an oral-periodontal evaluation and assessment of oral fluid biomarkers in patients with chronic hepatit…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus [Phase 4]
A Phase 4 clinical trial update investigates whether SGLT2 inhibitors can prevent liver complications in patients with chronic hepatitis B a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B [Phase 2]
A Phase 2 clinical trial evaluating VIR-2218 in combination with Peginterferon alfa-2a for Chronic Hepatitis B is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection [Phase 1]
This document reports a Phase 1 study to assess safety, tolerability, and pharmacokinetics of GIGA-2339 in participants with chronic hepatit…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Effect of Fufang Biejiaruangan Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis: A Multicenter, Randomized, Placebo-controlled Study [NA]
A multicenter randomized controlled trial evaluating whether Fufang Biejiaruangan plus antiviral therapy reduces hepatocellular carcinoma in…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: The Treatment of PD-1 Antibody Combined With Peg-IFNα in NAs-suppressed CHB Patients [NA]
Clinical trial update on a PD-1 antibody combined with Peg-IFNα in hepatitis B patients whose nucleos(t)ide analog therapy is suppressed. Th…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: [¹⁴C] Hydronidone Mass Balance Study [Phase 1]
Phase 1 mass balance pharmacokinetic study of [14C] Hydronidone in patients with chronic hepatitis B-related liver fibrosis; the trial is no…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Entecavir Resistance-Associated Mutations in Chronic HBV Patients in Turkey (STREAM Study)
A clinical study named STREAM is investigating entecavir resistance-related mutations in adults with chronic hepatitis B in Turkey; the tria…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Adaptability of an Undetectable = Untransmissible Model for HBV
This clinical trial update concerns an HBV study testing an undetectable = untransmissible model; the trial is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis B [Phase 1]
An early-phase Phase 1 clinical trial evaluating dose response and tolerability of the investigational drug IB-001 in healthy adults and ind…
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: Optimizing HBV Care Cascade Among Foreign-Born in the United States (FOCUS-HBV Study)
The FOCUS-HBV study, sponsored by NIDDK, has completed its trial evaluating strategies to optimize the hepatitis B care cascade among foreig…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: MR Elastography for Assessing Liver Fibrosis in Chronic Hepatitis B
A clinical trial is recruiting to evaluate MR elastography as a noninvasive method to assess liver fibrosis in patients with chronic hepatit…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Single Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Participants With Renal Impairment and in Healthy Participants With Normal Renal Function [Phase 1]
Phase 1 single-dose pharmacokinetics, safety and tolerability study of Pevifoscorvir Sodium (ALG-000184) in participants with renal impairme…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B [Phase 1, Phase 2]
This entry reports a Phase 1/2 clinical trial using umbilical cord mesenchymal stem cells to treat liver cirrhosis caused by chronic hepatit…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Chronic Hepatitis b Patients Switch to tAf After Discontinuation of Nucleoside Analogue [Phase 4]
Phase 4 trial update reports chronic hepatitis B patients switching to tenofovir alafenamide after stopping prior nucleoside analogue therap…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide
Clinical trial update indicating bulvertide is being studied for its effects on bile acids and gut microbiota in patients with Hepatitis D, …
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: Safety, Efficacy, Immunogenicity Study of GSK Biologicals' HBV Viral Vector and Adjuvanted Proteins Vaccine (GSK3528869A) in Adult Patients With Chronic Hepatitis B Infection [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating GSK3528869A, an HBV vaccine, in adults with chronic hepatitis B was terminated; results have been post…
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: The COMBAT HBV Feasibility Trial [Phase 4]
The COMBAT HBV feasibility trial (Phase 4) sponsored by the University of North Carolina has completed.
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Post-marketing Surveillance Study for the Safety of a DTaP-IPV- HB-PRP~T Vaccine in Republic of Korea
This is a completed post-marketing surveillance study assessing the safety of the DTaP-IPV-HB-PRP-T vaccine in Korea.
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Phase IIIc Clinical Study to Evaluate the Long-term Treatment of Hydronidone Capsules for Liver Fibrosis in Patients With Chronic Hepatitis B. [Phase 3]
Phase IIIc clinical trial to evaluate the long-term use of Hydronidone capsules for liver fibrosis in patients with chronic hepatitis B; sta…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot [NA]
Clinical trial update on screening for Hepatitis B, Hepatitis C, and AIDS viruses using dried blood spot; currently recruiting.
-
EMA approval · 2026-02-12EMA Authorised: Infanrix Hexa (Diphtheria toxoid;tetanus toxoid;Bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin);hepatitis B surface antigen;poliovirus (inactivated) (type-1 (Mahoney strain), type-2 (MEF-1 strain), type-3 (Saukett strain));Haemophilus influenzae type b polysaccharide) — GlaxoSmithKline Biologicals S.A.
The European Medicines Agency authorised Infanrix Hexa, a hexavalent vaccine that combines diphtheria, tetanus, pertussis, hepatitis B, poli…